Free Trial
→ Before you buy SpaceX shares, consider this alternative approach (From Weiss Ratings) (Ad)tc pixel Free BTTX Stock Alerts

Better Therapeutics (BTTX) Competitors

Better Therapeutics logo
Compare

BTTX vs. UPHL, ACONW, DHACW, LFMDP, and PIIIW

Should you buy Better Therapeutics stock or one of its competitors? MarketBeat compares Better Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Better Therapeutics include UpHealth (UPHL), Aclarion (ACONW), Digital Health Acquisition (DHACW), LifeMD (LFMDP), and P3 Health Partners (PIIIW). These companies are all part of the "healthcare" industry.

How does Better Therapeutics compare to UpHealth?

Better Therapeutics (NASDAQ:BTTX) and UpHealth (NYSE:UPHL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, media sentiment and valuation.

Better Therapeutics has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, UpHealth has a beta of 0.5, meaning that its stock price is 50% less volatile than the broader market.

Better Therapeutics has higher earnings, but lower revenue than UpHealth. Better Therapeutics is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A
UpHealth$130M0.00-$56.42M$1.470.00

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
UpHealth N/A N/A N/A

34.0% of Better Therapeutics shares are owned by institutional investors. Comparatively, 56.1% of UpHealth shares are owned by institutional investors. 51.4% of Better Therapeutics shares are owned by insiders. Comparatively, 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
Better Therapeutics Neutral
UpHealth Neutral

Summary

Better Therapeutics beats UpHealth on 4 of the 7 factors compared between the two stocks.

How does Better Therapeutics compare to Aclarion?

Better Therapeutics (NASDAQ:BTTX) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
Aclarion N/A N/A N/A

Aclarion has higher revenue and earnings than Better Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A
Aclarion$77.88KN/AN/AN/AN/A

34.0% of Better Therapeutics shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Aclarion had 5 more articles in the media than Better Therapeutics. MarketBeat recorded 5 mentions for Aclarion and 0 mentions for Better Therapeutics. Better Therapeutics' average media sentiment score of 0.00 beat Aclarion's score of -0.22 indicating that Better Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Better Therapeutics Neutral
Aclarion Neutral

Summary

Better Therapeutics beats Aclarion on 3 of the 5 factors compared between the two stocks.

How does Better Therapeutics compare to Digital Health Acquisition?

Digital Health Acquisition (NASDAQ:DHACW) and Better Therapeutics (NASDAQ:BTTX) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

Company Net Margins Return on Equity Return on Assets
Digital Health AcquisitionN/A N/A N/A
Better Therapeutics N/A N/A N/A

In the previous week, Digital Health Acquisition's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score.

Company Overall Sentiment
Digital Health Acquisition Neutral
Better Therapeutics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Health AcquisitionN/AN/AN/AN/AN/A
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A

34.0% of Better Therapeutics shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Better Therapeutics beats Digital Health Acquisition on 2 of the 2 factors compared between the two stocks.

How does Better Therapeutics compare to LifeMD?

LifeMD (NASDAQ:LFMDP) and Better Therapeutics (NASDAQ:BTTX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation, media sentiment and dividends.

Company Net Margins Return on Equity Return on Assets
LifeMDN/A N/A N/A
Better Therapeutics N/A N/A N/A

34.0% of Better Therapeutics shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

LifeMD has higher revenue and earnings than Better Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$193.33MN/AN/AN/AN/A
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A

In the previous week, LifeMD had 3 more articles in the media than Better Therapeutics. MarketBeat recorded 3 mentions for LifeMD and 0 mentions for Better Therapeutics. LifeMD's average media sentiment score of 0.29 beat Better Therapeutics' score of 0.00 indicating that LifeMD is being referred to more favorably in the media.

Company Overall Sentiment
LifeMD Neutral
Better Therapeutics Neutral

Summary

LifeMD beats Better Therapeutics on 3 of the 5 factors compared between the two stocks.

How does Better Therapeutics compare to P3 Health Partners?

Better Therapeutics (NASDAQ:BTTX) and P3 Health Partners (NASDAQ:PIIIW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

In the previous week, P3 Health Partners had 2 more articles in the media than Better Therapeutics. MarketBeat recorded 2 mentions for P3 Health Partners and 0 mentions for Better Therapeutics. P3 Health Partners' average media sentiment score of 0.43 beat Better Therapeutics' score of 0.00 indicating that P3 Health Partners is being referred to more favorably in the news media.

Company Overall Sentiment
Better Therapeutics Neutral
P3 Health Partners Neutral

P3 Health Partners has higher revenue and earnings than Better Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A
P3 Health Partners$1.47BN/AN/AN/AN/A

34.0% of Better Therapeutics shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
P3 Health Partners N/A N/A N/A

Summary

P3 Health Partners beats Better Therapeutics on 3 of the 5 factors compared between the two stocks.

Get Better Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTTX vs. The Competition

Export
MetricBetter TherapeuticsHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$4K$1.23M$6.52B$12.05B
Dividend YieldN/AN/A2.67%5.66%
P/E Ratio0.00N/A24.0024.42
Price / SalesN/A0.00515.84118.72
Price / CashN/AN/A27.4837.92
Price / BookN/A0.0010.606.82
Net Income-$39.76M-$56.42M$3.57B$337.56M

Better Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTTX
Better Therapeutics
N/AN/AN/AN/A$4KN/AN/A40
UPHL
UpHealth
N/A$0.00
flat		N/A+50.0%$6K$130MN/A1,750
ACONW
Aclarion
N/A$0.03
-9.2%		N/A-26.0%$0.00$77.88KN/A7
DHACW
Digital Health Acquisition
N/A$0.03
flat		N/AN/A$0.00N/AN/AN/A
LFMDP
LifeMD
N/A$23.33
-1.8%		N/A-2.2%$0.00$193.33MN/A230

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BTTX) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel